After treatment with the demethylating drug DAC (inhibitor of DNA methyltransferase), UCHL1 methylation levels were decreased in the NPC cell lines (Figure 2E and Supplementary Figure S2). Here, UCHL1 is linked to nasopharyngeal carcinoma.